0 reactions
indianmarketgrid The latest company update sets a five-year biosimilars revenue ambition, lifts planned manufacturing investment and separates higher-risk oncology funding.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid The latest company update sets a five-year biosimilars revenue ambition, lifts planned manufacturing investment and separates higher-risk oncology funding.